|
|
News Breaks
|
November 5, 2009
|
| 05:28 EDT |  | NVS |
| theflyonthewall.com: | Novartis receives regulatory approval for Celtura in Germany | | Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture-based Influenza A(H1N1) 2009 monovalent vaccine, Celtura. Novartis continues to pursue registration in other major countries, including Japan and Switzerland. :theflyonthewall.com |
|
|
News For NVS From The Last 14 Days Check below for free stories on NVS the last two weeks.
There are 10 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 13, 2012
|
| 06:38 EDT | | NVS |
| theflyonthewall.com: | Novartis: FDA requests additional data on Menveo for expanded use in children | | Novartis has received a Complete Response letter from the U.S. FFA on its application for the expanded use of Menveo, or Meningococcal Groups A, C, Y and W-135 Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, in infants and toddlers from 2 months of age. Menveo is already approved for use in individuals 2 to 55 years of age in the U.S.. Novartis submitted the supplemental Biologics License Application, or sBLA, for Menveo to the FDA in April 2011. The Complete Response letter indicates the FDA has completed the current review cycle and requests answers to additional questions prior to proceeding with further review of the sBLA. Novartis will work with the FDA to address these questions. :theflyonthewall.com |
|
|
February 10, 2012
|
| 07:10 EDT |  | NVS |
|
|
February 9, 2012
|
| 16:27 EDT |  | NVS |
| theflyonthewall.com: | Leerink's biotech and pharmaceuticals analysts hold a conference call | | Biotech Analysts Schimmer and Liang, along with Pharmaceuticals Analyst Fernandez, review the reimbursement process for drugs in France on an Analyst/Industry conference call. Relevant covered companies ACOR, AMGN, AMLN, AUXL, BIIB, BMY, GILD, HGSI, ITMN, JNJ, NVS, PFE and VRTX may be included on the Analyst/Industry conference call to be held on February 10 at 11 am. :theflyonthewall.com |
| | 09:47 EDT | | NVS |
|
|
February 7, 2012
|
| 13:45 EDT | | NVS |
| theflyonthewall.com: | Judge rules for FDA, against Sanofi, in generic Lovenox appeal, Bloomberg says |
 Subscribe for More Information :theflyonthewall.com |
|
|
February 6, 2012
|
| 07:04 EDT |  | NVS |
|
|
February 2, 2012
|
| 12:05 EDT | | NVS |
| theflyonthewall.com: | Novartis management to meet with Bernstein | | Meetings to be held in New York on February 7 and in Boston on February 8 hosted by Bernstein. :theflyonthewall.com |
|
|
February 1, 2012
|
| 05:30 EDT | | NVS |
| theflyonthewall.com: | Novartis Glivec label recommending extending treatment to 3yr gets FDA approval |
Subscribe for More Information :theflyonthewall.com |
|
|
January 31, 2012
|
| 18:26 EDT | | NVS |
| theflyonthewall.com: | Novartis unit loses patent ruling over Merck anti-fungal drug, Bloomberg says |
Subscribe for More Information :theflyonthewall.com |
| | 17:38 EDT | | NVS |
|
|
|
|
|
